Avecho Biotechnology Limited
AVEFF
$0.0045
-$0.0129-74.14%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 747.80K | 489.30K | 223.30K | 269.50K | 319.40K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 747.80K | 489.30K | 223.30K | 269.50K | 319.40K |
| Cost of Revenue | 304.20K | 315.10K | 323.30K | 331.60K | 341.00K |
| Gross Profit | 443.50K | 174.20K | -100.00K | -62.00K | -21.40K |
| SG&A Expenses | 1.34M | 1.28M | 1.22M | 1.41M | 1.63M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.77M | 2.64M | 2.50M | 2.54M | 2.60M |
| Operating Income | -2.02M | -2.15M | -2.28M | -2.27M | -2.28M |
| Income Before Tax | -2.06M | -2.18M | -2.29M | -2.28M | -2.29M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.06 | -2.18 | -2.29 | -2.28 | -2.29 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.06M | -2.18M | -2.29M | -2.28M | -2.29M |
| EBIT | -2.02M | -2.15M | -2.28M | -2.27M | -2.28M |
| EBITDA | -1.92M | -2.06M | -2.18M | -2.16M | -2.16M |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 12.68B | 12.11B | 11.55B | 10.31B | 9.07B |
| Average Diluted Shares Outstanding | 12.68B | 12.11B | 11.55B | 10.31B | 9.07B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |